Veracyte (VCYT) delivered second-quarter 2024 adjusted diluted earnings of 30 cents per share, up a stupendous 150% from the year-ago period’s level. The reported figure beat the Zacks Consensus Estimate of a loss of 3 cents per share.RevenuesRevenues increased 26.7% year over year to $114.4 million, which outpaced the Zacks Consensus Estimate by 14$107 million in the reported quarter, up 31% year over year. This rise was mainly due to increased Decipher and Affir ...